Detalhe da pesquisa
1.
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol;
2024 Jan 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38199301
2.
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.
Clin Gastroenterol Hepatol;
2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38729389
3.
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Clin Gastroenterol Hepatol;
21(10): 2483-2495.e1, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36731590
4.
Food Processing and Risk of Crohn's Disease and Ulcerative Colitis: A European Prospective Cohort Study.
Clin Gastroenterol Hepatol;
21(6): 1607-1616.e6, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36243353
5.
Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series.
J Gastroenterol Hepatol;
38(12): 2104-2110, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37710354
6.
WallFlex® and Evolution® Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction.
Dig Dis Sci;
68(9): 3688-3693, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37477765
7.
Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
Ann Intern Med;
175(10): 1374-1382, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36162111
8.
Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor.
Clin Gastroenterol Hepatol;
20(6): 1269-1281.e9, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34298191
9.
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Scand J Gastroenterol;
57(12): 1454-1462, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35819361
10.
Colonoscopy in France during the COVID-19 pandemic.
Int J Colorectal Dis;
36(5): 1073-1075, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33409566
11.
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Crit Care;
25(1): 417, 2021 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34872611
12.
Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.
Ann Intern Med;
170(2): 99-107, 2019 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30534946
13.
Reply.
Clin Gastroenterol Hepatol;
21(9): 2439, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36610501
14.
Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children.
Clin Gastroenterol Hepatol;
21(10): 2679-2681.e5, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36064096
15.
Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors.
Clin Res Hepatol Gastroenterol;
48(4): 102311, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38430989
16.
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study.
Arthritis Rheumatol;
2024 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38699822
17.
Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases: an overview.
J Clin Epidemiol;
: 111411, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38852893
18.
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis.
Aliment Pharmacol Ther;
59(4): 558-568, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38100159
19.
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.
Aliment Pharmacol Ther;
57(7): 792-799, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36578099
20.
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Aliment Pharmacol Ther;
57(4): 426-434, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36534763